Newsroom > Articles


Medexprim, the European leader in secure muti-omic Real-World data processing, is happy to announce its partnership with OpenRad, a remote radiology specialist, to promote the secondary use of high-quality Real-World imaging data.

As a Real-World data specialist based in France, Medexprim deploys its software suite and services in an expanding network of leading European university hospitals. In compliance with GDPR, Medexprim solutions extract, aggregate, curate, enrich, and deidentify health data from multiple sources to deliver complex, regulatory-grade, multi-omics, and multicentric datasets to serve oncology, neurology, and cardiology academic or industrial research projects.

Located in London and Berlin, OpenRad delivers innovative radiology solutions for diagnostic imaging centres worldwide. It aims to power better diagnostics by delivering an integrated, patient-first experience to healthcare professionals and the wider research community.

This preferred partnership promotes the optimized secondary use of imaging data by healthcare professionals, industrials, and clinical researchers for analysis, teaching, and algorithm training.

Romain Cazavan, CEO of Medexprim: “Imaging is an objective element of tumor/cancer evolution according to treatments, and in particular when the analysis is aimed at a longitudinal follow-up. As such, today, 40% of clinical research questions require an analysis of the image produced during treatment administration.”

Dominic Kirkman, Chief Revenue Officer of OpenRad: “We are excited to have announced the partnership with Medexprim at our launch at RSNA. This collaboration enables our customers to collect, de-identify, and augment medical imaging data for secondary uses, such as clinical research, teaching, and AI algorithms training”.

French version of the PR

About Openrad
Located in London and Berlin, OpenRad delivers innovative radiology solutions for static and mobile diagnostic imaging centres worldwide. OpenRad aims to empower healthcare professionals and the wider research community by connecting people, technology, and data. OpenRad can fully digitalise workflow processes within the radiological diagnostic sphere. Its zero-footprint SaaS based solutions speed up implementation, increase centre utilisation, provide remote access, and reduce cost of ownership. 

For further information on OpenRad, interview partners or visual material please contact: 
– Dillan Yogendra – Account Director at Silver Buck (PR agency) – 
– Katrin Lewandowski – OpenRad Head of Marketing & Communications – 

Please also visit our press room:

About Medexprim
Medexprim is the European leader in secure imaging and clinical data extraction to accelerate medical research. As a Real-World data specialist, Medexprim builds bridges between European academic hospitals, and pharmaceutical, AI and medical device companies. In compliance with the GDPR, Medexprim helps hospitals boost their clinical research strategy and valorize their data, through a suite of software and services designed with and for clinicians. Medexprim provides its partners with secure access to complex, regulatory-grade, multi-omics and multicentric datasets to serve oncology, neurology and cardiology, and help solve the “one patient, one disease, one treatment” equation to accelerate personalized medicine.

Medexprim Linkedin
Press contact: Anne-Sophie Labeta –

BC Platforms acquires Medexprim, paving the way for Global Leadership…

BC Platforms, a global leader in healthcare data management and analytics, today announced it…

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation.

Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions,…

Medexprim appoints Doctor Mercedes Serra as Head of Data Science…

Medexprim is proud to announce the appointment of Mercedes Serra as the Head of…

IQVIA clôture l’édition 2023 de son Accelerator Program, en collaboration…

IQVIA, spécialiste mondial d’analyses avancées, de solutions technologiques et de services de recherche clinique…